Spinal Cord Stimulation + Training for Spinal Cord Injury
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores the safety and practicality of using spinal cord transcutaneous stimulation (a non-invasive technique) combined with activity-based training to help individuals with recent spinal cord injuries improve arm, hand, and trunk function. It tests three approaches: the combination of stimulation and training, a placebo version, and training alone. Participants will engage in 10 sessions over two weeks, with follow-up visits to assess progress. Ideal candidates are those who have sustained a spinal cord injury in the neck area within the last eight weeks and experience difficulty using their hands.
As an unphased trial, this study provides a unique opportunity to contribute to pioneering research that could enhance rehabilitation options for spinal cord injury patients.
Will I have to stop taking my current medications?
The trial requires participants to stop taking anti-spasticity medications (like baclofen, Xeomin, and Lioresal) if they are unable or unwilling to wean off them.
What prior data suggests that spinal cord transcutaneous stimulation combined with activity-based training is safe for individuals with spinal cord injury?
Research has shown that spinal cord transcutaneous stimulation (scTS) is generally safe for people with spinal cord injuries. Studies have found that combining scTS with activity-based training (ABT) poses no major problems. For example, patients in various studies did not experience serious side effects. Some minor issues, such as skin irritation, were noted but remained manageable.
Activity-based training alone has also been evaluated for safety. Results indicate that it is well-tolerated even shortly after severe spinal cord injuries, with no serious side effects reported in early sessions.
Overall, both treatments appear safe and manageable for participants. They are carefully used to help improve movement and strength.12345Why are researchers excited about this trial?
Researchers are excited about spinal cord transcutaneous stimulation (scTS) combined with activity-based training (ABT) for spinal cord injury because it offers a unique approach that differs from traditional rehabilitation methods. Unlike other treatments, which often focus solely on physical therapy, this method uses customized electrical stimulation to target specific spinal segments, potentially enhancing neural plasticity and recovery. The stimulation is applied non-invasively through electrodes placed on the skin, making it less intrusive than surgical options. Additionally, by combining scTS with ABT, there's potential for improved motor function and quality of life, as the stimulation might amplify the benefits of physical training.
What evidence suggests that this trial's treatments could be effective for spinal cord injury?
Research has shown that spinal cord transcutaneous stimulation (scTS) combined with activity-based training (ABT) may improve hand and arm function in people with spinal cord injuries. In this trial, one group will receive active scTS with ABT, while another group will receive sham scTS with ABT to control for placebo effects. In one study, 72% of participants experienced improved strength and function in their hands and arms with the combination of scTS and ABT. Another study found that scTS with ABT led to significant recovery in people with long-term spinal cord injuries, although it required several sessions. These findings suggest that this combined approach might lead to better recovery than traditional methods.678910
Who Is on the Research Team?
Gail Forrest, PhD
Principal Investigator
Kessler Foundation
Are You a Good Fit for This Trial?
This trial is for individuals with recent cervical spinal cord injuries who are currently in an inpatient rehabilitation program. It's designed to see if a combination of skin-level spinal stimulation and activity-based training can help improve the use of their hands, arms, and trunk.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive one of the three interventions (scTS+ABT, sham scTS+ABT, or ABT only) for 10 sessions over 2 weeks.
Follow-up
Participants are monitored for safety and effectiveness after treatment with assessments at 1-month, 2-month, and 3-month follow-up visits.
What Are the Treatments Tested in This Trial?
Interventions
- Activity-based Training
- Spinal Cord Transcutaneous Stimulation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Kessler Foundation
Lead Sponsor